Rash associated with piperacillin/tazobactam administration in infectious mononucleosis

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 996-998

  LeClaire, Aimée C ^a   Martin, Craig A ^a,b   Hoven, Ardis D ^c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Infectious mononucleosis; Piperacillin tazobactam; Rash

Indexed keywords

AMPICILLIN; GENTAMICIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG METABOLISM; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMUR FRACTURE; FEVER; HEADACHE; HOSPITALIZATION; HUMAN; INFECTIOUS MONONUCLEOSIS; MALE; MUSCLE WEAKNESS; NAUSEA; OSTEOMYELITIS; PENICILLIN ALLERGY; PRIORITY JOURNAL; RASH; RHINORRHEA; SIDE EFFECT;

ADULT; ANTI-BACTERIAL AGENTS; DRUG COMBINATIONS; DRUG ERUPTIONS; HUMANS; INFECTIOUS MONONUCLEOSIS; MALE; PENICILLANIC ACID; PIPERACILLIN;

EID: 2442711877     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D378     Document Type: Article

References (14)

1. Schooley RT. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. 5th ed. Philadelphia: Churchill Livingstone, 2000:1599-612.
2. Chretien JH, Esswein JG. How frequent is bacterial superinfection of the pharynx in infectious mononucleosis? Observations on incidence, recognition, and management with antibiotics. Clin Pediatr (Phila) 1976;15:424-7.
3. Geyman JP, Erickson S. The ampicillin rash as a diagnostic and management problem: case reports and literature review. J Fam Pract 1978;7:493-6.
4. Haverkos HW, Amsel Z, Drotman DP. Adverse virus-drug interactions. Rev Infect Dis 1991;13:697-704.
5. Levy M. The combined effect of viruses and drugs in drug-induced diseases. Med Hypotheses 1984;(14):293-6.
6. Levy M. Role of viral infections in the induction of adverse drug reactions. Drug Saf 1997;16:1-8.
7. Pauszek ME. Making a rash diagnosis: amoxicillin therapy in infectious mononucleosis. Indiana Med 1990;83:330-1.
8. Renn CN, Straff W, Dorfmuller A, Al-Masaoudi T, Merk HF, Sachs B. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002;147:1166-70.
9. McCloskey GL, Massa MC. Cephalexin rash in infectious mononucleosis. Cutis 1997;59:251-4.
10. Lupton JR, Figueroa P, Tamjidi P, Berberian BJ, Sulica VI. An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction. Cutis 1999;64:91-6.
11. Dakdouki GK, Obeid KH, Kanj SS. Azithromycin-induced rash in infectious mononucleosis. Scan J Infect Dis 2002;34:939-41.
12. Schissel DJ, Singer D, David-Bajar K. Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction. Cutis 2000;65:163-6.
13. McKenzie H, Parratt D, White RG. IgM and IgG antibody levels to ampicillin in patients with infectious mononucleosis. Clin Exp Immunol 1976;26:214-21.
14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.